Resistance to gefitinib and cross-resistance to irreversible EGFR-TKIs mediated by disruption of the Keap1-Nrf2 pathway in human lung cancer cells

Seong Hee Park, Jae Hwan Kim, Eunsun Ko, Jeong Yub Kim, Myung Jin Park, Min Jung Kim, Hyemin Seo, Shibo Li, Ji Yun Lee

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Resistance to gefitinib and cross-resistance to irreversible EGFR-TKIs mediated by disruption of the Keap1-Nrf2 pathway in human lung cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds